KEY INSIGHTS REPORT
Geopolitical instability is reshaping global supply chains. Biological threats are growing more sophisticated. Climate change is putting food systems and natural resources under pressure. And health systems are being asked to do more with less, even as the promise of precision medicine grows clearer by the year. Genomic data and technologies have a role to play in tackling all these challenges.
Genomics can help us develop crops that withstand a changing climate, build the data infrastructure that powers AI-driven medicine, detect biological threats before they become crises and unlock economic growth across Canada’s life sciences, agri-food and natural resource sectors. But realizing this potential—and securing a competitive edge for Canada on this technological frontier—requires more than excellent science. It demands coordinated, purposeful action designed not just to generate knowledge, but to deliver solutions at national scale.
That’s what Genome Canada is built to do. Over 25 years, we’ve helped establish Canada as a recognized leader in genomics science, laying a strong research foundation, supporting world-class talent and funding groundbreaking research projects. In 2020, we made a strategic decision to transform our approach from that of a more traditional research funder toward mission-driven innovation, aligning Canadian genomics capabilities and community toward specific challenges and solutions. Our white paper, Mission-Driven Research: How Genome Canada Tackles Complex Problems, explains how.
From funding research to delivering solutions
Investigator-led research, scientific excellence and peer review remain essential. What’s changed is how we organize around them. Mission-driven innovation begins with a question most research programs don’t ask upfront: what specific solution does Canada need, and what will it take to deliver it?
Rather than funding research with uncertain impacts, we identify concrete national challenges, define what success looks like, then build coordinated portfolios of research, infrastructure and partnerships to get there. We invest 12 to 18 months consulting end users, policymakers and communities before any research funding flows—ensuring missions address real-world priorities and that the people who need solutions help shape them.
The result is a fundamentally different relationship between science and impact: discoveries connected—from the beginning—to the systems and pathways needed to put them to work.
Six dimensions of how we work
Integrated solutions, not disciplinary silos. Every initiative begins with a clearly articulated problem requiring cross-sector answers. Our precision health initiative asks how genomic medicine can reach all Canadians equitably. Our agri-food initiative asks how Canada builds climate-resilient food systems. Neither can be answered by a single discipline.
Coherent portfolios, not individual projects. When we define a problem, we design a wholistic portfolio needed to solve it—crop research, data platforms, engagement programs, knowledge mobilization—each component selected because it fits a larger architecture of change.
Real-world solutions, not just research outputs. We aren’t just investing in human genome sequencing to discover new genetic markers. We’re working to transform how health care is delivered to every Canadian—building the data infrastructure, clinical tools and governance frameworks that make genomic medicine a practical reality.
Balanced innovation investment, not risk aversion. Transformative results require taking on ambitious projects and accepting that not every path succeeds. We embrace that, while maintaining accountability through milestone-based management that keeps missions on track.
Directional national leadership, not neutral facilitation. We actively align Canada’s genomics capacity with national priorities: climate adaptation, pandemic preparedness, biosecurity, economic competitiveness.
Strategic ecosystem orchestration, not basic coordination. Our national vantage point and unique federated network with regional Genome Centres lets us align provincial initiatives, connect researchers across regions and ensure distributed efforts reinforce one another. That orchestration often creates more value than our direct funding alone.
What we’ve learned
Mission-driven coordination enhances rather than compromises scientific quality—the science gets better because its purpose is clearer. Clear goals are the engine of alignment: when participants across sectors can see exactly what they’re working toward, coordination becomes energizing rather than burdensome. And our role as convener and connector—bringing coherence to distributed capabilities—is often where the greatest value is created.
Why this matters now
Canada’s ability to maintain sovereignty, economic competitiveness and the health of its people and environment depends on turning scientific capability into practical solutions at speed and scale. Genomics powers AI-ready data infrastructure, strengthens biosecurity and pandemic preparedness, builds resilience into food systems and supports the sustainable management of natural resources. It is strategic national infrastructure.
Genome Canada’s mission-driven approach is how we ensure that capacity translates into impact—coordinated national efforts aligned around Canada’s most pressing challenges, designed to deliver results that reach people, industries and communities across the country.
This paper shares what we’ve built and what we’ve learned. We hope it’s useful to others navigating similar questions about how to connect scientific excellence to the solutions Canada needs most.
Read the full paper: Mission-Driven Research: How Genome Canada Tackles Complex Problems.
Learn more about Genome Canada’s 2025–2030 mission focus areas. View our Strategic Directions.
About Genome Canada
Genome Canada is a national not-for-profit leading large-scale research missions that translate excellent science into economic, health and environmental solutions. We align Canada’s genomics ecosystem for impact.